一款全球首创新药的诞生,往往被寄予成为重磅炸弹的期望。
但现实并非全部如此……
近日,一家在纳斯达克上市的Biote...查看全文
牛唐2019-08-16 21:39
$Nabriva Therapeutics(NBRV)$ Lefamulin将在8月19号进行审批,药效确实还不错,但Contepo在4月30日吃了CRL,股价一直下跌,此次Lefamulin获批可能性还是较大的,不过考虑到投资人对抗生素的认可度比较低(参考$Achaogen(AKAO)$ ),市场的反应大概率应该是sell on news查看全文
苏泽逸2019-04-21 08:13
$Achaogen(AKAO)$ 抗生素研发并不是一个好的赛道,Achaogen股票已从过去52周的15美元高点跌逾98%,周二收于0.16美元,该公司估值约为1000万美元。另外三家开发创新抗生素的公司Paratek、Tetraphase市场和Nabriva股价从过去52周高点分别下跌了56%、75%和56%。查看全文
$Achaogen(AKAO)$ 8-K - Current report Filed: 2019-04-23 AccNo: 0001564590-19-012533 Size: 32 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 8.01: Other Events 网页链接
$Achaogen(AKAO)$ 8-K - Current report Filed: 2019-04-22 AccNo: 0001564590-19-012336 Size: 439 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a RegistrantIte...
$Achaogen(AKAO)$ 8-K - Current report Filed: 2019-04-18 AccNo: 0001564590-19-012012 Size: 151 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sh...
$Achaogen(AKAO)$ 8-K - Current report Filed: 2019-04-15 AccNo: 0001564590-19-011576 Size: 81 KBItem 1.03: Bankruptcy or ReceivershipItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 8.01: Other EventsItem 9.01: ...
$Achaogen(AKAO)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-04-12 AccNo: 0000921895-19-001077 Size: 133 KB 网页链接
$Achaogen(AKAO)$ 8-K - Current report Filed: 2019-04-08 AccNo: 0001564590-19-011021 Size: 32 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 5.02: Departure of Directors or Certain Officers; Election of Dire...
$Achaogen(AKAO)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-04-05 AccNo: 0000921895-19-001029 Size: 131 KB 网页链接
$Achaogen(AKAO)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-04-01 AccNo: 0001564590-19-010412 Size: 14 MB 网页链接
$Achaogen(AKAO)$ 8-K - Current report Filed: 2019-03-28 AccNo: 0001564590-19-009847 Size: 190 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Achaogen(AKAO)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-03-28 AccNo: 0000921895-19-000924 Size: 132 KB 网页链接